HIV and its rhesus macaque (RM) counterpart SIV share a pattern of infection and a constellation of immunologic and pathobiologic features such that the vast majority of susceptible (untreated) people or RM infected with these agents experience unremitting infection and progressive immune deficiency. In work funded by this grant, we pioneered analysis of the in vivo immunobiology of naive vs. memory (TN vs. TM) and central vs. effector memory (TCM vs. TEM) T cells in the RM model (including their homeostatic and functional regulation) and demonstrated the direct relevance of this physiology to SIV pathogenesis and immunity. In particular, we demonstrated that the mechanisms that maintain CD4* TCM homeostasis and regulate CD4''TCM differentiation into CD4* TEM determine the development of immunodeficiency (AIDS) in SIV-infected RM. More recently, we have: 1) shown that IL-7 and IL-15 are critical regulators of CD4* TCM homeostasis in RM, 2) developed a TN-deficient RM model and used this model to show that CD4* TN are dispensable for both 004"^ TCM stability and CD4* TEM production in SIV-infected RM, and 3) developed a method for long-term in vivo IL-15 blockade in RM (a "rhesusized" anti-IL-15 mAb) and used this method to show the importance of IL-15 in TEM homeostasis and that complete NK depletion (a second consequence of IL-15 blockade) has little impact on virologic control and disease progression in SIV-infected RM. In the extension of this work, we will use the CD4* and CD8* TN depletion models and in vivo manipulation of IL-15 and IL-7 to define the fundamental mechanisms underlying: 1) SIV persistence and replication set points (immune evasion vs. immune control), 2) deterioration of 004"^ T cell-mediated and overall immunity leading to AIDS, and 3) the establishment and maintenance of SIV reservoirs and immune reconstitution following pharmacologic control of viral replication (using ART regimens capable of long-term suppression of SIV in RM to <30 RNA copies/mL of plasma and improved methods for monitoring residual viral RNA and DNA in tissues). Identification of these mechanisms will be a crucial step in the development of novel therapeutic approaches aimed at enhancing immune control of HIV replication, "disconnecting" HIV replication from disease progression, and/or augmenting imnnune recovery and reservoir clearance during anti-retroviral therapy.

Public Health Relevance

Although the advent of modern anti-retroviral therapies has been nothing short of miraculous, the danger posed by HIV to infected individuals has not been eliminated as complete pharmacologic control of viral replication is not always achievable and current therapies cannot eliminate HIV reservoirs. The SIV/rhesus macaque model of AIDS allows detailed analysis of the immunologic mechanisms that enable HIV to persist and to damage the immune system. The studies proposed in this grant will provide critical information for rational development of novel therapies aimed at improving health outcomes in HIV+ subjects by eliminating or reducing HIV reservoirs and enhancing functional restoration of their immune systems.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37AI054292-11
Application #
8433547
Study Section
Special Emphasis Panel (NSS)
Program Officer
Sharma, Opendra K
Project Start
2003-01-01
Project End
2018-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
11
Fiscal Year
2013
Total Cost
$905,851
Indirect Cost
$388,222
Name
Oregon Health and Science University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Del Prete, Gregory Q; Park, Haesun; Fennessey, Christine M et al. (2014) Molecularly tagged simian immunodeficiency virus SIVmac239 synthetic swarm for tracking independent infection events. J Virol 88:8077-90
Hansen, Scott G; Piatak Jr, Michael; Ventura, Abigail B et al. (2013) Immune clearance of highly pathogenic SIV infection. Nature 502:100-4
Okoye, Afam A; Picker, Louis J (2013) CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev 254:54-64
Klatt, Nichole R; Canary, Lauren A; Vanderford, Thomas H et al. (2012) Dynamics of simian immunodeficiency virus SIVmac239 infection in pigtail macaques. J Virol 86:1203-13
Picker, Louis J; Hansen, Scott G; Lifson, Jeffrey D (2012) New paradigms for HIV/AIDS vaccine development. Annu Rev Med 63:95-111
Okoye, Afam A; Rohankhedkar, Mukta; Abana, Chike et al. (2012) Naive T cells are dispensable for memory CD4+ T cell homeostasis in progressive simian immunodeficiency virus infection. J Exp Med 209:641-51
Kuhrt, David; Faith, Seth; Hattemer, Angela et al. (2011) Naive and memory B cells in the rhesus macaque can be differentiated by surface expression of CD27 and have differential responses to CD40 ligation. J Immunol Methods 363:166-76
Leone, Amanda; Rohankhedkar, Mukta; Okoye, Afam et al. (2010) Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses. J Immunol 185:1650-9
Okoye, Afam; Park, Haesun; Rohankhedkar, Mukta et al. (2009) Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis. J Exp Med 206:1575-88
Picker, Louis J; Reed-Inderbitzin, Edward F; Hagen, Shoko I et al. (2006) IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J Clin Invest 116:1514-24